Oppenheimer downgraded Prestige Consumer (PBH) to Perform from Outperform.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PBH:
- Prestige Consumer Healthcare Issues Fiscal 2026 Results, Outlook
- Prestige Consumer Healthcare: Buy Rating Reaffirmed Despite Soft Outlook, with Acquisitions and Undervalued Earnings Power Seen as Upside Drivers
- Prestige Consumer reports Q4 adjusted EPS $1.23, consensus $1.39
- Prestige Consumer to acquire LaCorium Health for $150M in cash
- Prestige Consumer price target lowered to $65 from $77 at Oppenheimer